Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs) |
| |
Authors: | Stephen Gorsuch Vassilios Bavetsias Martin G. Rowlands G. Wynne Aherne Paul Workman Michael Jarman Edward McDonald |
| |
Affiliation: | Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Cancer Research UK Laboratories, Cotswold Road, Sutton, Surrey, SM2 5NG, UK |
| |
Abstract: | High-throughput screening led to the identification of isothiazolones 1 and 2 as inhibitors of histone acetyltransferase (HAT) with IC50s of 3 μM and 5 μM, respectively. Analogues of these hit compounds with variations of the N-phenyl group, and with variety of substituents at C-4, C-5 of the thiazolone ring, were prepared and assayed for inhibition of the HAT enzyme PCAF. Potency is modestly favoured when the N-aryl group is electron deficient (4-pyridyl derivative 10 has IC50 = 1.5 μM); alkyl substitution at C-4 has little effect, whilst similar substitution at C-5 causes a significant drop in potency. The ring–fused compound 38 has activity (IC50 = 6.1 μM) to encourage further exploration of this bicyclic structure. The foregoing SAR is consistent with an inhibitory mechanism involving cleavage of the S–N bond of the isothiazolone ring by a catalytically important thiol residue. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|